Literature DB >> 4556572

A new subunit influenza vaccine: acceptability compared with standard vaccines and effect of dose on antigenicity.

F L Ruben, G G Jackson.   

Abstract

Mesh:

Substances:

Year:  1972        PMID: 4556572     DOI: 10.1093/infdis/125.6.656

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  28 in total

1.  Attenuated influenza A vaccine (Alice) in an adult population: vaccine-related illness, serum and nasal antibody production, and intrafamily transmission.

Authors:  T E Minor; E C Dick; C R Dick; S L Inhorn
Journal:  J Clin Microbiol       Date:  1975-11       Impact factor: 5.948

Review 2.  Inactivated influenza vaccines: recent progress and implications for the elderly.

Authors:  Valentina Parodi; Daniela de Florentiis; Mariano Martini; Filippo Ansaldi
Journal:  Drugs Aging       Date:  2011-02-01       Impact factor: 3.923

3.  A surface antigen influenza vaccine. 2. Pyrogenicity and antigenicity.

Authors:  M I Brady; I G Furminger
Journal:  J Hyg (Lond)       Date:  1976-10

4.  A new surface-antigen-adsorbed influenza virus vaccine. II. Studies in a volunteer group.

Authors:  C W Potter; R Jennings; C McLaren; D Edey; C H Stuart-Harris; M Brady
Journal:  J Hyg (Lond)       Date:  1975-12

5.  Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects.

Authors:  Robert B Couch; Patricia Winokur; Rebecca Brady; Robert Belshe; Wilbur H Chen; Thomas R Cate; Bryndis Sigurdardottir; Amy Hoeper; Irene L Graham; Robert Edelman; Fenhua He; Diane Nino; Jose Capellan; Frederick L Ruben
Journal:  Vaccine       Date:  2007-09-14       Impact factor: 3.641

6.  [A new influenza subunit vaccine: reactogenicity and antigenicity in comparison to split and whole virus vaccines (author's transl)].

Authors:  C Kunz; H Hofmann; H Bachmayer; E Liehl; A Moritz
Journal:  Infection       Date:  1976       Impact factor: 3.553

7.  Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly.

Authors:  W A Keitel; T R Cate; R L Atmar; C S Turner; D Nino; C M Dukes; H R Six; R B Couch
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

8.  High dose trivalent influenza vaccine compared to standard dose vaccine in patients with rheumatoid arthritis receiving TNF-alpha inhibitor therapy and healthy controls: Results of the DMID 10-0076 randomized clinical trial.

Authors:  Jack T Stapleton; Nancy Wagner; Rebecca Tuetken; Abbie R Bellamy; Heather Hill; Sonnie Kim; Patricia L Winokur
Journal:  Vaccine       Date:  2020-04-12       Impact factor: 3.641

Review 9.  Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.

Authors:  Kwang-Chul Kwon; Dheeraj Verma; Nameirakpam D Singh; Roland Herzog; Henry Daniell
Journal:  Adv Drug Deliv Rev       Date:  2012-10-23       Impact factor: 15.470

10.  Humoral and secretory antibody responses to immunization with low and high dosage split influenza virus vaccine.

Authors:  F L Ruben; C W Potter; C H Stuart-Harris
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.